GENE ONLINE|News &
Opinion
Blog

Series B Funding
China’s Qitan Technology Raises Over RMB400 Million in Series B Funding to Develop Nanopore Gene Sequencing
2021-06-23
Boundless Bio Raises Fresh Capital to Boost extrachromosomal DNA Targeting Therapeutic Efforts
2021-04-30
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
North Carolina-Based Gene Therapy Startup Bags $81.5 Million in Series B Funding
2021-03-17
Acepodia Raises $47 Million Funding to Nurture its Next-Gen, oNK Cell Therapy Assets
2021-03-17
With $74 Million in Fresh Capital, Belgian Startup Aims to Advance its Regenerative Pathway Modulators
2021-03-11
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy
2021-01-15
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Neuron23 Emerges from Stealth with $113.5 Million Financing
2020-12-18
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
Dewpoint Snags Successful Series B to Target Lesser Known Cellular Compartments
2020-10-02
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top